Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

World Immunoprotein Diagnostic Testing Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets

Research and Markets
Posted on: 31 Jul 17

The "World Immunoprotein Diagnostic Testing Market - Opportunities and Forecasts, 2014 - 2022" report has been added to Research and Markets' offering.

Immunoprotein is a protein with immunological activity, which provides immunity against pathogenic organisms or substances. Immunoproteins form the integrated body system of tissues, organs, cells or cell products that neutralizes antigens. These proteins enable the diagnosis of various diseases as they display an abnormal increase in their blood concentration when in a diseased state.

High prevalence of cancers, cardiovascular diseases, allergies, urological disorders and orthopaedic diseases are the major drivers of the global immunoprotein diagnostic testing market.

The global market for immunoprotein diagnostic testing is expected to witness a healthy CAGR during the forecast period due to the advantage of rapid diagnosis provided by this kind of testing.

Roche, Diasorin, AdnaGen, Randox Laboratories, Abcam PLC, Siemens, The Binding Site, Abbott Laboratories, Enzo Life Sciences, Agilent Technologies, BioMerieux and Thermo Fisher Scientific are some of the key players in this market.

KEY BENEFITS

  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global immunoprotein diagnostic testing market
  • Porter's Five Forces analysis examines the competitive structure of the global immunoprotein diagnostic testing market and would assist market strategists in making decisions.
  • In-depth coverage of the global immunoprotein diagnostic testing market including drivers, restraints and opportunities would help professionals to better understand market behavior
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the global immunoprotein diagnostic testing market would be informative for professionals in the corporate sector

KEY MARKET SEGMENTS

MARKET BY TYPE

  • C-Reactive Protein Diagnostic Tests
  • Complement System Protein Diagnostic Tests
  • Pre-Albumin Diagnostic Tests
  • Haptoglobin Diagnostic Tests
  • Immunoglobulin Diagnostic Tests
  • Free Light Chain Diagnostic Tests

MARKET BY APPLICATION

  • Autoimmune Testing
  • Infectious Disease Testing
  • Allergy Testing
  • Endocrine Testing

For more information about this report visit https://www.researchandmarkets.com/research/fr48cs/world

View source version on businesswire.com: http://www.businesswire.com/news/home/20170731005676/en/

Business Wire
www.businesswire.com

Last updated on: 31/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.